DZ634A1 - Mutants de vibrio cholerale non-toxinogènes. - Google Patents

Mutants de vibrio cholerale non-toxinogènes.

Info

Publication number
DZ634A1
DZ634A1 DZ847164A DZ847164A DZ634A1 DZ 634 A1 DZ634 A1 DZ 634A1 DZ 847164 A DZ847164 A DZ 847164A DZ 847164 A DZ847164 A DZ 847164A DZ 634 A1 DZ634 A1 DZ 634A1
Authority
DZ
Algeria
Prior art keywords
mutants
vibrio cholera
peptide
vibrio cholerae
toxigenic vibrio
Prior art date
Application number
DZ847164A
Other languages
English (en)
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Application granted granted Critical
Publication of DZ634A1 publication Critical patent/DZ634A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/909—Vibrio

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DZ847164A 1983-04-29 1984-04-25 Mutants de vibrio cholerale non-toxinogènes. DZ634A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/489,958 US4882278A (en) 1983-04-29 1983-04-29 Non-toxinogenic vibrio cholerae mutants

Publications (1)

Publication Number Publication Date
DZ634A1 true DZ634A1 (fr) 2004-09-13

Family

ID=23945983

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ847164A DZ634A1 (fr) 1983-04-29 1984-04-25 Mutants de vibrio cholerale non-toxinogènes.

Country Status (20)

Country Link
US (1) US4882278A (fr)
EP (1) EP0125228B1 (fr)
JP (1) JPH0740921B2 (fr)
AT (1) ATE35152T1 (fr)
AU (1) AU585481B2 (fr)
CA (1) CA1326218C (fr)
DE (1) DE3472114D1 (fr)
DK (1) DK213784A (fr)
DZ (1) DZ634A1 (fr)
EG (1) EG17879A (fr)
ES (1) ES531986A0 (fr)
GR (1) GR81986B (fr)
IE (1) IE57266B1 (fr)
IL (1) IL71652A (fr)
PH (1) PH25301A (fr)
PT (1) PT78478B (fr)
YU (1) YU45616B (fr)
ZA (1) ZA843142B (fr)
ZM (1) ZM2884A1 (fr)
ZW (1) ZW6884A1 (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135862A (en) * 1983-03-04 1992-08-04 University Of Maryland Method of isolating restriction fragment deletions in vibrio cholerae, products thereof
US5399494A (en) * 1983-03-04 1995-03-21 The University Of Maryland System Vibrio cholerae strain CVD103Hgr, method of making same, and vaccines derived therefrom
US5882653A (en) * 1983-03-04 1999-03-16 The University Of Maryland System Vibrio cholerae 01 (CVD111) and non-01 (CVD112 and CVD112RM) serogroup vaccine strains, methods of making same and products thereof
US5470729A (en) * 1983-03-04 1995-11-28 University Of Maryland At Baltimore Method of isolating restriction fragment deletions in Vibrio cholerae, and products thereof
US5308835A (en) * 1984-07-09 1994-05-03 Praxis Biologics, Inc. Production of the E. coli LT-B enterotoxin subunit
US4808700A (en) * 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
CA1340372C (fr) * 1984-07-09 1999-02-02 John D. Clements Production d'une sous-unite d'enterotoxine lt-b d'e. coli
EP0249449A1 (fr) * 1986-06-11 1987-12-16 Enterovax Research Pty. Ltd. Souche bactérienne pour vaccins vivants
SE462285B (sv) * 1988-09-16 1990-05-28 Jan Roland Holmgren Expression av koleratoxinets bindande subenhet med hjaelp av fraemmande promotor- och/eller ledarpeptidstrukturer
US6043057A (en) * 1988-09-16 2000-03-28 Vitec Aktiebolag Recombinant systems for expression of the cholera B-sub-unit with the aid of foreign promoters and/or leader peptides
AU656730B2 (en) * 1990-06-05 1995-02-16 University Of Maryland At Baltimore Method of isolating restriction fragment deletions in vibrio cholerae, and products thereof
IL101715A (en) * 1991-05-02 2005-06-19 Amgen Inc Recombinant dna-derived cholera toxin subunit analogs
WO1994001533A1 (fr) * 1992-07-06 1994-01-20 President And Fellows Of Harvard College Mutants de deletion utilises en tant que vaccins contre le cholera
US5874088A (en) * 1992-07-06 1999-02-23 President And Fellows Of Harvard College Deletion mutants of cholera vaccines expressing heterologous antigens
JPH08506963A (ja) * 1993-02-22 1996-07-30 ザ ジェネラル ホスピタル コーポレーション 生ワクチン菌株における異種抗原
US6203799B1 (en) 1993-07-01 2001-03-20 Presidents And Fellows Of Harvard College Vibrio cholerae mutants which are soft-agar penetration defective and lack a functional CtxA subunit
US5945285A (en) * 1996-06-27 1999-08-31 President And Fellows Of Harvard College Vibrio cholerae having increased sensitivity to antibiotics
US6036953A (en) * 1996-11-29 2000-03-14 The General Hospital Corporation Heterologous antigens in live cell V. cholerae strains
JP4086945B2 (ja) * 1996-12-10 2008-05-14 カウンシル・オブ・サイエンティフィック・アンド・インダストリアル・リサーチ 非毒性Ｖ．Ｃｈｏｌｅｒａｅ株の単離法およびその株由来のコレラワクチンの製造法
EP0928831B1 (fr) * 1997-12-10 2006-05-03 Council of Scientific and Industrial Research Organismes cholerae, vaccins et leur préparation
US7390619B1 (en) 1998-02-11 2008-06-24 Maxygen, Inc. Optimization of immunomodulatory properties of genetic vaccines
US6541011B2 (en) 1998-02-11 2003-04-01 Maxygen, Inc. Antigen library immunization
CA2320960A1 (fr) * 1998-02-11 1999-08-19 Maxygen, Inc. Optimisation des proprietes immunomodulatrices des vaccins genetiques
AU5366099A (en) 1998-08-20 2000-03-14 Connaught Laboratories Limited Nucleic acid molecules encoding inclusion membrane protein of (chlamydia)
US6693087B1 (en) 1998-08-20 2004-02-17 Aventis Pasteur Limited Nucleic acid molecules encoding POMP91A protein of Chlamydia
US6686339B1 (en) * 1998-08-20 2004-02-03 Aventis Pasteur Limited Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
RU2155227C1 (ru) * 1999-06-07 2000-08-27 Иркутский научно-исследовательский противочумный институт Сибири и Дальнего Востока Штамм бактерий vibrio cholerae cholerae 5 серовара огава - продуцент антител холерной огава сыворотки
AU1013601A (en) 1999-10-22 2001-05-08 Aventis Pasteur Limited Method of inducing and/or enhancing an immune response to tumor antigens
EP1792995A3 (fr) 2000-05-08 2007-06-13 Sanofi Pasteur Limited Antigènes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci
ATE346925T1 (de) * 2000-05-10 2006-12-15 Sanofi Pasteur Ltd Durch mage minigene kodierte immunogene polypeptide und ihre verwendungen
WO2002036777A1 (fr) * 2000-11-02 2002-05-10 The National University Of Singapore Gene aopb, proteine, homologues, fragments et variants de celui-ci, ainsi que l'utilisation de ces derniers pour presentation a la surface cellulaire
ATE369895T1 (de) 2002-04-09 2007-09-15 Sanofi Pasteur Ltd Modifizierte cea nucleinsäure und expressionsvektoren
RU2222594C1 (ru) * 2002-07-15 2004-01-27 Федеральное государственное учреждение Российский научно-исследовательский противочумный институт "Микроб" Штамм бактерий vibrio cholerae км206 классического биовара серовара огава - продуцент протективных антигенов
WO2004019978A1 (fr) * 2002-08-29 2004-03-11 National University Of Singapore Acide nucleique recombinant utile pour induire une reponse immunitaire de protection contre des allergenes
US8562970B2 (en) * 2003-10-08 2013-10-22 Sanofi Pasteur Limited Modified CEA/B7 vector
US20060099229A1 (en) * 2004-11-05 2006-05-11 Universiti Sains Malaysia Vibrio cholerae strains VCUSM1 and VCUSM4, method of producing same, and vaccine derivatives thereof
US7049423B2 (en) 2003-12-19 2006-05-23 The General Hospital Corporation Use of the RTX secretion system to achieve heterologous polypeptide secretion by Vibrio cholerae

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264737A (en) * 1978-09-21 1981-04-28 President And Fellows Of Harvard College Method of making genetically stable mutants of vibrio cholerae
US4328209A (en) * 1979-04-11 1982-05-04 Board Of Regents, The University Of Texas System Cholera vaccine
JPS5893837A (ja) * 1981-11-30 1983-06-03 Toyota Motor Corp 複合材料及びその製造方法
US4666837A (en) * 1982-05-24 1987-05-19 Smithkline-Rit DNA sequences, recombinant DNA molecules and processes for producing the A and B subunits of cholera toxin and preparations containing so-obtained subunit or subunits
US5135862A (en) * 1983-03-04 1992-08-04 University Of Maryland Method of isolating restriction fragment deletions in vibrio cholerae, products thereof
ZA841557B (en) * 1983-03-04 1984-10-31 Univ Maryland Method of isolating restriction fragment deletions in vibrio chlolerae,and products thereof

Also Published As

Publication number Publication date
AU2727084A (en) 1984-11-01
EG17879A (en) 1991-08-30
JPH0740921B2 (ja) 1995-05-10
IL71652A0 (en) 1984-07-31
GR81986B (fr) 1984-12-12
PT78478A (en) 1984-05-01
DK213784A (da) 1984-10-30
PT78478B (en) 1986-05-27
IE57266B1 (en) 1992-07-01
DK213784D0 (da) 1984-04-27
CA1326218C (fr) 1994-01-18
US4882278A (en) 1989-11-21
ZA843142B (en) 1985-03-27
AU585481B2 (en) 1989-06-22
EP0125228B1 (fr) 1988-06-15
ZW6884A1 (en) 1984-09-19
ES8600649A1 (es) 1985-09-01
DE3472114D1 (en) 1988-07-21
YU76384A (en) 1989-08-31
EP0125228A1 (fr) 1984-11-14
ES531986A0 (es) 1985-09-01
JPS6037980A (ja) 1985-02-27
YU45616B (sh) 1992-07-20
PH25301A (en) 1991-04-30
IE841043L (en) 1984-10-29
ATE35152T1 (de) 1988-07-15
ZM2884A1 (en) 1985-04-22
IL71652A (en) 1988-11-30

Similar Documents

Publication Publication Date Title
DK213784D0 (da) Ikke-toxinogene vibrio choleraemutanter
DK219087D0 (da) Vektorsystem til brug ved transformation af trichoderma, transformerede trichodermastammer og fremgangsmaade til fremstilling af proteiner heri
MX9203458A (es) Segmentos inmunogenicos que contienen glicoproteinas quimericas de las glicoproteinas de virus sincitial respiratorio humano.
EP0672116A4 (fr) Mutants de deletion utilises en tant que vaccins contre le cholera.
KR970009347B1 (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
GB2149301B (en) Pyridine-soluble extract - refined detoxified endotoxin composition and use
GR80840B (en) Novel polypeptide with a - amylase inhibiting effect, method for the preparation thereof, use and pharmaceutical preparations thereof
NO165478C (no) Fremgangsmaate for fremstilling av antigeniske preparater.
BG41137A3 (bg) Метод за получаване на днк преносен вектор,предназначен за поддържане и репликация на дезоксинуклеотидна последо- вателност,кодираща човешки препроинсулин
AU4458785A (en) Production of the E. Coli LT-B entertoxin subunit
DK151284D0 (da) Fremgangsmaade til isolation af mutanter af vibrio cholerae
IL58103A (en) Sila-substituted 1,4-dihydropyridine derivatives,their production and pharmaceutical compositions containing them
IE810618L (en) Pasteurella vaccines
SE8205247D0 (sv) Fiskvacciner
JO1343B1 (en) Non-toxic gene variant strains of vibro cholera
WO1990012807A3 (fr) Procede et anticorps purifies a specificite elevee contre des produits genetiques, y compris des retinoblastomes
IT7830203A0 (it) Procedimento per rinforzare prodotti di carbone dolce.
AR224831A1 (es) Un procedimiento para la elaboracion de preparados de paredes celulares o preparaciones de celulas completas de propionibacterium granulosum dsm 1773,propionibacterium avidum dms 1772 y/o propionibacterium acnes atcc 6919
GB2022573A (en) New antibiotics from micromonospora globosa, and pharmaceutical compositions containing them
IT8124936A0 (it) Procedimento per la combustione diprodotti, essenzialmente legnosi, polverizzati nella conduzione di forni per calce.
IT211414Z2 (it) Piano di fuoco per caminetto con preriscaldamento dell'aria.